RULE NO.:RULE TITLE:
64B13-3.010Standards of Practice
NOTICE OF CHANGE
Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 45 No. 207, October 23, 2019 issue of the Florida Administrative Register.
The change is in response to written comments submitted by the staff of the Joint Administrative Procedures Committee and discussion and subsequent vote by the Board at the public telephonic meeting held September 11, 2020. This is a second Notice of Change for the rule. The previous Notice of Change published in Vol. 46, No. 162, of the August 19, 2020, issue of the Florida Administrative Register. The rule shall now read as follows:
64B13-3.010 Standards of Practice.
(1) through (2) No change.
(3) Certified optometrists employing the topical ocular pharmaceuticals listed in subsection 64B13-18.002(8), F.A.C., Anti-Glaucoma Agents, shall comply with the following:
(a) through (b) No change.
(c) The certified optometrist shall have available, and be proficient in the use of, the following instrumentation:
1. through 5. No change.
6. Binocular indirect ophthalmascope and non-contact fundus lens A device to provide stereoscopic view of the optic nerve and fundus.
(4) through (5) No change.
(6)(a) To be in compliance with paragraph 64B13-3.007(2)(f), F.A.C., certified optometrists shall perform a pharmacologic dilated fundus examination during the patient’s initial presentation, and thereafter, whenever medically indicated. Fundus imaging is not a substitute for a pharmacologic dilated fundus examination. If, in the certified optometrist’s sound professional judgment, dilation is not performed because of the patient’s age, physical limitations, or conditions, the reason(s) shall be noted in the patient’s medical record.
(b) No change.
(7) through (12) No change.
Rulemaking Authority 463.005(1) FS. Law Implemented 463.005(1), 463.0055, 463.0135(1) FS. History–New 9-16-80, Amended 12-20-82, Formerly 21Q-3.10, Amended 7-11-88, 6-18-92, 1-28-93, Formerly 21Q-3.010, Amended 3-16-94, Formerly 61F8-3.010, Amended 8-24-94, 9-21-94, 2-13-95, 12-31-95, Formerly 59V-3.010, Amended 6-15-00, 2-7-01, 11-16-05, 11-5-07, 11-4-08, 8-25-16, .
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Dr. Anthony Spivey, Executive Director, Board of Optometry, 4052 Bald Cypress Way, Bin #C07, Tallahassee, FL 32399-3257; Anthony.Spivey@flhealth.gov.
